Results 291 to 300 of about 848,177 (365)

Reduced rates of diabetic retinopathy complications with use of continuous glucose monitoring. [PDF]

Sci Rep
Alsoudi AF, Wai KM, Koo E, Koo E, Mruthyunjaya P, Rahimy E.   +5 more
europepmc   +1 more source

The Influence of Ultra-Wide field Fluorescein Angiography on the Diagnosis and Management of Diabetic Retinopathy. [PDF]

J Vitreoretin Dis
Scripsema NK, Al-Khaled T, Song A, Hallak JA, Allozi R, Khanifar AA, Papakostas TD, Weng CY, Gentile RC, Campbell JP, Lee JG, Landa G, Chau FY, Mieler WF, Gupta M, Fawzi AA, Kim JE, Lim JI, Chan RVP.   +18 more
europepmc   +1 more source

Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease—A practical update for clinicians

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Albuminuria, the abnormal presence of albumin in urine, is a key marker of kidney damage and a strong predictor of kidney and cardiovascular outcomes. Its clinical significance has evolved from early historical observations to its current role in chronic kidney disease (CKD) detection, risk stratification and treatment monitoring.
Jelle M. Beernink, Dominique van Mil, Gozewijn D. Laverman, Hiddo J. L. Heerspink, Ron T. Gansevoort   +4 more
wiley   +1 more source

Editorial: Advances in the research of diabetic retinopathy, volume III. [PDF]

Front Endocrinol (Lausanne)
Nawaz MI, Rezzola S.
europepmc   +1 more source

Global, regional and national burden of blindness and vision loss attributable to diabetic retinopathy, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Diabetes is increasingly reported as a cause of blindness and vision loss. However, the trends in the burden of blindness and vision loss attributed to diabetic retinopathy (DR) have yet to be fully elucidated. Materials and Methods Utilizing the latest data from the Global Burden of Disease Study 2021, we extracted prevalence and years ...
Yujie Pan, Yunkuo Li, Mengzhao Cui, Guangyu He, Guixia Wang   +4 more
wiley   +1 more source

Modulation of Oxidative Stress in Diabetic Retinopathy: Therapeutic Role of Natural Polyphenols. [PDF]

Antioxidants (Basel)
Gómez-Jiménez V, Burggraaf-Sánchez de Las Matas R, Ortega ÁL.   +2 more
europepmc   +1 more source

Neurobeachin (NBEA) is a novel gene associated with GLP‐1 receptor agonist associated weight loss

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Nearly 42% of adults in the United States have obesity, a significant risk factor for many cardiometabolic diseases and cancers. Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are promising interventions for weight loss, but their efficacy varies significantly across individuals.
Arshiya Mariam‐Smith, Joseph H. Breeyear, Noah J. Daniels, Kevin M. Pantalone, Marcio L. Griebeler, Alison A. Motsinger‐Reif, Daniel M. Rotroff   +6 more
wiley   +1 more source

VEGF in Diabetic Retinopathy and Age-Related Macular Degeneration. [PDF]

Int J Mol Sci
Callan A, Heckman J, Tah G, Lopez S, Valdez L, Tsin A.   +5 more
europepmc   +1 more source

Statin therapy and neuropathy in type 1 diabetes: A cross‐sectional study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Dyslipidaemia contributes to the pathogenesis of diabetic peripheral neuropathy (DPN). While statins improve cardiovascular outcomes in diabetes, their potential neurotoxic effects remain debated. This study examined the impact of statin use on neuropathy in type 1 diabetes mellitus (T1DM). Materials and Methods Participants with T1DM (n =
Raabya Pasha, Anoushka Kamath, Zara Linn, Alise Kalteniece, Bilal Bashir, Jonathan D. Schofield, Rayaz Malik, Shazli Azmi, Maryam Ferdousi, Handrean Soran   +9 more
wiley   +1 more source